About Loop Dx

Loop Diagnostics (Loopdx) has developed a new first-class in vitro cellular immunoassay that detects sepsis within the first hour of bloodstream infection. Our patented method and kit identify immune activity biomarkers with a sensitivity 3 times greater than the leading competitor, PCT. Additionally, our diagnostic process is 10 times faster than pathogen identification. Loopdx recently received EU funding to bring the technology to market and the current plan is to have disposable assays availView more